The title crystal structure (sytematic name: 2-(5-acetyl-2,3-dihydrobenzofuran-2-yl)allyl (E)-3-(4-hydroxyphenyl) acrylate) is shown in the gure. Tables 1 and 2 contain details of the measurement method and a list of the atoms including atomic coordinates and displacement parameters. gummy extract was obtained. A portion of the extract (16 g) was ltered and submitted to a medium pressure column chromatography system composed of an 2.5 cm x 48 cm medium pressure column (Aceglass inc, Vineland, NY, USA) packed with silicagel (Kieselgel 60 H, Merck, Darmstadt, Germany) using an isocratic solvent system of hexane-ethyl acetate (8:2 v:v) pumped with a medium pressure pump (FMI lab pump, Syosset, NY, USA) with a ow rate of 10 mLminute. The fractions were collected using a Gilson FC 203B fraction collector (Gilson, Middleton, MI, USA) and the volume of each fraction was 5 mL·The collected fractions (140) were combined according to TLC analysis (Kieselgel F254 plates, developed with CHCl 3 : EtOAc 18:2 v/v, and spots visualized by spraying with vanillin: sulfuric acid 2% in ethanol and heating) and 17 combined fractions were obtained. Fraction eight (1.5 g) was re-chromatographed using the same system and 22 mg of umbelliferone [1] were isolated. Fraction 11 (3.5 g) was chromatographed using the mentioned system and the title compound [2] was isolated (525 mg). Suitable crystals for a crystallographic study were obtained after re-crystallization from hexane: ethyl acetate 9:1 v/v. The structure was already reported, however, we have revised and corrected NMR data [1] with the
. . All distances and angles are in the normal range. All proton NMR spectroscopic evidence was similar to that previously published [2] .
